𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Methylation changes in promoter and enhancer regions of the WT1 gene in Wilms’ tumours

✍ Scribed by Jaroslav Mareš; Vı́tězslav Křı́ž; Andreas Weinhäusel; Šárka Vodičková; Roman Kodet; Oskar A. Haas; Zdeněk Sedláček; Petr Goetz

Book ID
117466841
Publisher
Elsevier Science
Year
2001
Tongue
English
Weight
300 KB
Volume
166
Category
Article
ISSN
0304-3835

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The clinical relevance of Wilms Tumour 1
The clinical relevance of Wilms Tumour 1 (WT1) gene mutations in acute leukaemia
✍ Carolyn Owen; Jude Fitzgibbon; Peter Paschka 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 116 KB

## Abstract Recurrent genetic aberrations are important predictors of outcome in acute myeloid leukaemia (AML). Numerous novel molecular abnormalities have been identified and investigated in recent years adding to the risk stratification and prognostication of conventional karyotyping. Mutations i

THE EXPRESSION PATTERN OF WILMS' TUMOUR
THE EXPRESSION PATTERN OF WILMS' TUMOUR GENE (WT1) PRODUCT IN NORMAL TISSUES AND PAEDIATRIC RENAL TUMOURS
✍ RAMANI, PRAMILA; COWELL, JOHN K. 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 791 KB

W T l , the Wilms' tumour suppressor gene located at chromosome llp13, plays an important role in the development of the kidney. It is mutated in 10 per cent of Wilms' tumours (WTs) and their putative precursors called nephrogenic rests (NRs). A sensitive immunohistochemical technique was establishe